JAGSNPHARM — Jagsonpal Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for Jagsonpal Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	471	1,146	1,479	1,287	1,062
Net Total Accounts Receivable
Net Total Receivables	156	249	157	143	172
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,091	1,646	1,993	1,612	1,431
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	226	243	93	88.4	73.5
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,642	1,949	2,171	2,783	3,167
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	270	276	191	259	283
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	315	361	297	383	405
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1,328	1,589	1,874	2,400	2,762
Total Liabilities & Shareholders' Equity	1,642	1,949	2,171	2,783	3,167
Total Common Shares Outstanding